To Homepage

Improved Pre-eclampsia Management With sFlt-1/PlGF Ratio

Speakers: Martin Overgaard, Denmark; Paul Guerby, France; Ignacio Herraiz, Spain; Roman Kapustin, Russia

Learn from health care professionals who already introduced sFlt-1/PlGF in their clinical routine. The webinar is dedicated to the topic of improved diagnosis and prognosis of pre-eclampsia with the aid of sFlt-1/PlGF biomarker ratio.

Program

  • Implementation of sFlt-1/PlGF ratio in clinical routine: A retrospective study
    Martin Overgaard, Denmark
  • Evaluation of the prognostic value of the sFlt-1/PlGF ratio in early-onset pre-eclampsia
    Paul Guerby, France
  • The aid of sFlt-1/PlGF ratio in pre-eclampsia patient management on examples of clinical cases
    Ignacio Herraiz, Spain
  • Clinical value of pre-eclampsia biomarkers in high-risk pregnancies: Case reports
    Roman Kapustin, Russia
  • Q&A

Not all products are CE marked or have 510(k) clearance for sale in the U.S. Availability of products in each country depends on local regulatory marketing authorization status.